- Home
- A-Z Publications
- Current Cardiology Reviews
- Previous Issues
- Volume 19, Issue 2, 2023
Current Cardiology Reviews - Volume 19, Issue 2, 2023
Volume 19, Issue 2, 2023
-
-
Stem Cells and Congenital Heart Disease: The Future Potential Clinical Therapy Beyond Current Treatment
Authors: Katherine Julian, Nikita Garg, Narutoshi Hibino and Rohit JainCongenital heart disease (CHD) is the most common congenital anomaly in newborns. Current treatment for cyanotic CHD largely relies on the surgical intervention; however, significant morbidity and mortality for patients with CHD remain. Recent research to explore new avenues of treating CHD includes the utility of stem cells within the field. Stem cells have since been used to both model and potentially treat CHD. Read More
-
-
-
CHARGE-AF: A Useful Score For Atrial Fibrillation Prediction?
Authors: Christos Goudis, Stylianos Daios, Fotios Dimitriadis and Tong LiuAtrial fibrillation (AF) is the commonest arrhythmia in clinical practice and is associated with increased morbidity and mortality. Various predictive scores for new-onset AF have been proposed, but so far, none have been widely used in clinical practice. CHARGE-AF score was developed from a pooled diverse population from three large cohorts (Atherosclerosis Risk in Communities study, Cardiovascular Health Study and Framin Read More
-
-
-
The Wider Considerations in Closing Chronic Disease Gaps – Focus on Heart Failure and Implementation
Background: Heart failure (HF) is predominately a chronic disease. There are overlaps in HF and chronic disease research and care. Chronic disease and HF research are conducted with multiple goals. The overarching goal is “optimized patient outcomes at maximum costeffectiveness”. However, observations on patients can come with many variables; thus, we see differences in clinical translation. This document discuss Read More
-
-
-
Modern Concepts of the Role of Fine Particles (PM 2.5) in the Genesis of Atherosclerosis and Myocardial Damage: Clinical and Epidemiological Data, the Main Pathophysiological Mechanisms
Authors: Aleksey M. Chaulin and Artem Konstantinovich SergeevDue to the fact that atherosclerotic cardiovascular diseases (CVDs) dominate in the structure of morbidity, disability and mortality of the population, the study of the risk factors for the development of atherosclerotic CVDs, as well as the study of the underlying pathogenetic mechanisms thereof, is the most important area of scientific research in modern medicine. Understanding these aspects will allow improving the set of treat Read More
-
-
-
Heart Failure And Type 2 Diabetes Mellitus: Neurohumoral, Histological And Molecular Interconnections
Authors: A. Ushakov, V. Ivanchenko and A. GagarinaHeart failure (HF) is a global healthcare burden and a leading cause of morbidity and mortality worldwide. Type 2 diabetes mellitus (T2DM) appears to be one of the major risk factors that significantly worsen HF prognosis and increase the risk of fatal cardiovascular outcomes. Despite a great knowledge of pathophysiological mechanisms involved in HF development and progression, hospitalization rates in patients with HF and Read More
-
-
-
Responses Triggered by the Immune System in Hypertensive Conditions and Repercussions on Target Organ Damage: A Review
Background: Hypertension is a chronic, multifactorial clinical condition characterized by sustained high blood pressure levels. It is often associated with functional-structural alterations of target organs, which include heart, brain, kidneys, and vasculature. Objective: This study highlights the recent correlation between the immune system and hypertension and its repercussions on target-organ damage. Methods: The descript Read More
-
-
-
Review of Randomized Controlled Trials in Patients with Peripartum Cardiomyopathy
Authors: Jasmin Mujkanovic and Abbas A. QayyumIntroduction: Peripartum cardiomyopathy (PPCM) is a rare but potentially lifethreatening disease, defined as idiopathic cardiomyopathy occurring towards the end of pregnancy or in the months following delivery, abortion or miscarriage. We aim to raise awareness of this condition and give an overview of current knowledge as well as an insight and comparison of clinical trials focusing on randomized controlled trials. Material a Read More
-
-
-
Hypertrophic Cardiomyopathy in Saudi Arabia: A Systematic Review of the Epidemiological, Clinical, and Imaging Features
More LessBackground: A systematic review was performed to deliver a critical view of clinical and research practice on hypertrophic cardiomyopathy (HCM) in Saudi Arabia. Scopus, PubMed, and Google Scholar databases were searched for original articles reporting clinical and/or imaging findings among HCM patients in Saudi Arabia. Of 559 records identified, 3 studies and 1 abstract were included, involving 169 patients. Methods: Read More
-
-
-
Possible Long-Term Cardiovascular Effects of COVID-19
Authors: Gloria A. Lugo, Hamasah Nizami, Fiyad Haniff, Lilly Su, Denise Marsh, Shefali Gupta, Rohit Jain and Heenam GoelCoronavirus Disease 2019 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has become a worldwide pandemic. Since 2019, the virus has mutated into multiple variants that have made it harder to eradicate and have increased the rate of infection. This virus can affect the structure and the function of the heart and can lead to cardiovascular symptoms that can have long-lasting effects despit Read More
-
-
-
Takotsubo Cardiomyopathy and COVID-19: A Case Report and Literature Review
Background: Takotsubo cardiomyopathy is characterized by transient regional ventricular abnormalities in the absence of coronary artery disease and is reported as a complication of COVID-19. Case Presentation: It can have a diverse clinical presentation, occasionally resembling an acute coronary syndrome, and progress to acute heart failure and cardiogenic shock, adversely affecting patients' prognosis. A high index of s Read More
-
-
-
Quadricuspid Pulmonary Valve: Case Report and the Comparison with Quadricuspid Aortic Valve
Authors: Toshiharu Miyake, Tomohiro Inoue and Sotaro MushiakeBackground: Quadricuspid pulmonary valve (QPV) is a rare congenital anomaly. Simple QPV had been mainly diagnosed at the time of autopsy before 2000, and the frequency rates of QPV are approximately 0.02%–0.41%. QPV was initially diagnosed using transthoracic echocardiography (TTE) after 2000 and with contrast computed tomography (CT) or cardiac magnetic resonance imaging (CMR) after 2009. Obtaining the Read More
-
Volumes & issues
-
Volume 21 (2025)
-
Volume 20 (2024)
-
Volume 19 (2023)
-
Volume 18 (2022)
-
Volume 17 (2021)
-
Volume 16 (2020)
-
Volume 15 (2019)
-
Volume 14 (2018)
-
Volume 13 (2017)
-
Volume 12 (2016)
-
Volume 11 (2015)
-
Volume 10 (2014)
-
Volume 9 (2013)
-
Volume 8 (2012)
-
Volume 7 (2011)
-
Volume 6 (2010)
-
Volume 5 (2009)
-
Volume 4 (2008)
-
Volume 3 (2007)
-
Volume 2 (2006)
-
Volume 1 (2005)
Most Read This Month
Article
content/journals/ccr
Journal
10
5
false
en
